Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
12 February 2025 - 12:20PM
Edgar (US Regulatory)
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that
this Schedule 13G Amendment No. 4 dated February 11, 2025 relating to the Common Stock, par value $0.001 per share, of Marinus Pharmaceuticals,
Inc. shall be filed on behalf of the undersigned.
|
SUVRETTA CAPITAL MANAGEMENT, LLC
By: /s/ Aaron Cowen |
|
Name: Aaron Cowen |
|
Title: Authorized Signatory |
|
AVERILL MASTER FUND, LTD.
By: /s/ Aaron Cowen |
|
Name: Aaron Cowen |
|
Title: Director |
|
AARON COWEN
By: /s/ Aaron Cowen |
Exhibit B
CONTROL PERSON IDENTIFICATION
Suvretta Capital Management, LLC is the relevant entity for which
Aaron Cowen is the control person.
Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Jan 2025 to Feb 2025
Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Feb 2024 to Feb 2025